# M7824 in Subjects With HPV Associated Malignancies

> **NCT03427411** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 57 (actual)

## Conditions studied

- Human Papilloma Virus
- Cervical Cancer
- Oropharyngeal Cancer
- Anal Cancer
- Vaginal or Penile Cancer

## Interventions

- **DRUG:** M7824

## Key facts

- **NCT ID:** NCT03427411
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-27
- **Primary completion:** 2021-02-02
- **Final completion:** 2022-12-31
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2023-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03427411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03427411, "M7824 in Subjects With HPV Associated Malignancies". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03427411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*